Otras preguntas frecuentes sobre el autismo

Encontrará información básica sobre temas como “¿Qué es?” y “¿Cuántas personas tienen este trastorno?” en la sección ASD: Información sobre el trastorno. Las otras preguntas frecuentes que son específicas para un tema determinado se responden en esta sección.

Citas

  1. Cohen, D., Pichard, N., Tordjman, S., Baumann, C., Burglen, L., Excoffier, E., et al. (2005). Specific genetic disorders and autism: Clinical contribution towards their identification. Journal of Autism Developmental Disorders, 35(1), 103–116.
  2. Kumar, R. A., & Christian, S. L. (2009). Genetics of autism spectrum disorders. Current Neurology and Neuroscience Reports, 9(3), 188–197.
  3. Tuchman, R., & Rapin, I. (2002). Epilepsy in autism. Lancet Neurology, 1, 352–358. 
  4. Smalley, S. L. (1998). Autism and tuberous sclerosis. Journal of Autism and Developmental Disorders, 28(5), 407–414. 
  5. Wiznitzer, M. (2004). Autism and tuberous sclerosis. Journal of Child Neurology, 19(9), 675–679. 
  6. Kielinen, M., Rantala, H., Timonen, E., Linna, S. L., & Moilanen, I. (2004). Associated medical disorders and disabilities in children with autistic disorder: A population-based study. Autism, 8(1), 49–60. 
  7. Goodlin-Jones, B. L, Tassone, F., Gane, L. W., & Hagerman, R. J. (2004). Autistic spectrum disorder and the fragile X premutation. Journal of Developmental and Behavioral Pediatrics, 25(6), 392–398. 
  8. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. (2013). American Psychiatric Association: Washington, DC.
  9. Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008). Psychiatric disorders in children with autism spectrum disorders: Prevalence, comorbidity, and associated factors in a population-derived sample. Journal of the American Academy of Child and Adolescent Psychiatry, 47(8), 921–929. 
  10. National Institute of Mental Health. (2010). Anxiety disorders. Obtenido el 31 de mayo de 2012 en http://www.nimh.nih.gov/health/publications/anxiety-disorders/index.shtml en el contenido de Inglés
  11. National Institute of Mental Health. (2012). Attention deficit hyperactivity disorder (ADHD).   Obtenido el 31 de mayo de 2012 en http://www.nimh.nih.gov/health/publications/attention-deficit-hyperactivity-disorder/index.shtml en el contenido de Inglés
  12. Autism Speaks. (2013). Answers to Frequently Asked Questions about DSM-5. Obtenido el 11 de octubre de 2013 en http://www.autismspeaks.org/dsm-5/faq en el contenido de Inglés Notificacion de salida
  13. Jain, A., Marshall, J., Buikema, A., Bancroft, T., Kelly, J. P., & Newschaffer, C. J. (2015). Autism occurrence by MMR vaccine status among US children with older siblings with and without autism. JAMA, 313(15), 1534–1540. Obtenido el 8 de septiembre de 2016 en http://www.ncbi.nlm.nih.gov/pubmed/25898051 en el contenido de Inglés
  14. Owley, T., McMahon, W., Cook, E. H., Laulhere, T., South, M., Mays, L. Z., et al. (2001). Multisite, double-blind, placebo-controlled trial of porcine secretin in autism. Journal of the American Academy of Child & Adolescent Psychiatry, 40(11), 1293–1299. 
  15. Owley, T., Steele, E., Corsello, C., Risi, S., McKaig, K., Lord, C., et al. (1999). Double-blind, placebo-controlled trial of secretin for the treatment of autistic disorder. Medscape General Medicine, Oct 6, E2.
  16. Levy, S.E., Giarelli, E., Lee, L.C., Schieve, L.A., Kirby, R.S., Cunniff, C. (2010). Autism spectrum disorder and co-occurring developmental, psychiatric, and medical conditions among children in multiple populations of the United States. J Dev Behav Pediatr, 31, 267-275. Retrieved March 2, 2018, from https://www.ncbi.nlm.nih.gov/pubmed/20431403 en el contenido de Inglés